As per the USFDA, Princeton-based Dr Reddy's Laboratories Inc is recalling 2,040 bottles of 15 mg Morphine Sulfate extended-release tablets due to "Failed Impurities/Degradation Specification".

HYDERABAD, India, November 26, 2024--Dr. Reddy's Laboratories, Inc. and Senores Pharmaceuticals, Inc. today announced the launch of Ivermectin Tablets USP, 3 mg in ...

The Department of Pharmaceuticals (DoP) has rejected review applications from five companies including AstraZeneca and Lupin while upholding the ceiling price fixed for various strengths of modified ...

Learn about cost, uses, and more for metoprolol oral tablet, a generic prescription drug used for conditions like high blood pressure and angina.

HYDERABAD, India, May 03, 2024--Dr. Reddy's Laboratories announces the launch of Doxycycline Capsules, 40 mg* in the U.S. market.

Dr. Reddy’s Laboratories Ltd. has initiated a voluntary recall of six lots of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg. The reason behind the recall is the presence of powder ...

Recalls Dr. Reddy’s Issues Voluntary Nationwide Recall of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg Due to Sub-Potency ...

Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as "Dr. Reddy's"), today announced that it is voluntarily ...

Lupin Receives Approval From U.S. FDA For Metoprolol Succinate Extended-Release Tablets USP The product will be manufactured at Lupin’s Pithampur facility in India.

Dr. Reddy’s Saxagliptin and Metformin Hydrochloride Extended-Release Tablets are supplied in a strength of 2.5 mg/1000 mg in bottle count of 60 and strengths of 5 mg/500 mg and 5 mg/1000 mg each ...